T. Rowe Price Associates’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.88M Buy
21,758
+2,933
+16% +$388K ﹤0.01% 1484
2025
Q1
$2.62M Buy
18,825
+1,053
+6% +$146K ﹤0.01% 1494
2024
Q4
$2.76M Buy
17,772
+2,578
+17% +$400K ﹤0.01% 1488
2024
Q3
$2.77M Buy
15,194
+1,170
+8% +$213K ﹤0.01% 1488
2024
Q2
$1.67M Buy
14,024
+2,309
+20% +$274K ﹤0.01% 1648
2024
Q1
$1.26M Sell
11,715
-7,869
-40% -$845K ﹤0.01% 1801
2023
Q4
$1.95M Sell
19,584
-28,836
-60% -$2.88M ﹤0.01% 1543
2023
Q3
$5.76M Sell
48,420
-104,096
-68% -$12.4M ﹤0.01% 1149
2023
Q2
$27.2M Sell
152,516
-14,596
-9% -$2.6M ﹤0.01% 852
2023
Q1
$27.6M Sell
167,112
-58,146
-26% -$9.59M ﹤0.01% 837
2022
Q4
$35.5M Sell
225,258
-45,939
-17% -$7.23M 0.01% 761
2022
Q3
$40.8M Sell
271,197
-2,437,918
-90% -$367M 0.01% 711
2022
Q2
$445M Buy
2,709,115
+1,274
+0% +$209K 0.06% 313
2022
Q1
$603M Sell
2,707,841
-17,699
-0.6% -$3.94M 0.06% 297
2021
Q4
$647M Buy
2,725,540
+30,030
+1% +$7.13M 0.06% 303
2021
Q3
$629M Buy
2,695,510
+318,890
+13% +$74.4M 0.06% 307
2021
Q2
$489M Sell
2,376,620
-201,200
-8% -$41.4M 0.05% 340
2021
Q1
$530M Sell
2,577,820
-62,544
-2% -$12.8M 0.05% 323
2020
Q4
$566M Sell
2,640,364
-15,633
-0.6% -$3.35M 0.06% 304
2020
Q3
$485M Sell
2,655,997
-11,103
-0.4% -$2.03M 0.06% 305
2020
Q2
$492M Sell
2,667,100
-7,131
-0.3% -$1.31M 0.06% 298
2020
Q1
$540M Buy
2,674,231
+89,469
+3% +$18.1M 0.09% 245
2019
Q4
$484M Sell
2,584,762
-33,648
-1% -$6.3M 0.06% 311
2019
Q3
$418M Sell
2,618,410
-860,473
-25% -$137M 0.06% 311
2019
Q2
$876M Buy
3,478,883
+640,425
+23% +$161M 0.12% 181
2019
Q1
$679M Buy
2,838,458
+58,239
+2% +$13.9M 0.1% 211
2018
Q4
$638M Buy
2,780,219
+2,508,062
+922% +$576M 0.11% 196
2018
Q3
$77M Buy
272,157
+19,013
+8% +$5.38M 0.01% 756
2018
Q2
$74.3M Buy
253,144
+13,306
+6% +$3.91M 0.01% 750
2018
Q1
$60.5M Buy
239,838
+7,670
+3% +$1.94M 0.01% 808
2017
Q4
$50.1M Sell
232,168
-4,737
-2% -$1.02M 0.01% 856
2017
Q3
$44M Sell
236,905
-6,344
-3% -$1.18M 0.01% 893
2017
Q2
$42M Buy
243,249
+908
+0.4% +$157K 0.01% 897
2017
Q1
$37M Buy
242,341
+14,941
+7% +$2.28M 0.01% 917
2016
Q4
$33.5M Buy
227,400
+8,750
+4% +$1.29M 0.01% 946
2016
Q3
$27.6M Buy
218,650
+24,200
+12% +$3.06M 0.01% 1015
2016
Q2
$21.9M Buy
194,450
+12,900
+7% +$1.45M ﹤0.01% 1070
2016
Q1
$18.9M Buy
181,550
+42,410
+30% +$4.41M ﹤0.01% 1102
2015
Q4
$15.7M Buy
139,140
+14,840
+12% +$1.67M ﹤0.01% 1156
2015
Q3
$13.6M Buy
124,300
+4,200
+3% +$460K ﹤0.01% 1224
2015
Q2
$11.5M Buy
120,100
+20,000
+20% +$1.91M ﹤0.01% 1313
2015
Q1
$9.32M Buy
100,100
+5,400
+6% +$503K ﹤0.01% 1353
2014
Q4
$7.76M Buy
94,700
+5,500
+6% +$450K ﹤0.01% 1387
2014
Q3
$5.73M Buy
89,200
+500
+0.6% +$32.1K ﹤0.01% 1434
2014
Q2
$5.39M Buy
88,700
+7,700
+10% +$468K ﹤0.01% 1447
2014
Q1
$4.85M Buy
81,000
+900
+1% +$53.9K ﹤0.01% 1437
2013
Q4
$5.1M Buy
80,100
+4,900
+7% +$312K ﹤0.01% 1428
2013
Q3
$5.11M Buy
75,200
+2,700
+4% +$183K ﹤0.01% 1420
2013
Q2
$5.22M Buy
+72,500
New +$5.22M ﹤0.01% 1398